Active	Status	Sponsor type	Region	Phase	Filter
10 Active 0 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

10 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Patel, Ankit B
RETHINK-1, NCT04994483: Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease	Active, not recruiting	3	750	Canada, US, RoW	Simufilam, PTI-125, Placebo	Cassava Sciences, Inc., Premier Research Group plc	Alzheimer Disease	10/24	10/24
JIVAN, NCT05861947: A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies	Recruiting	1	30	RoW	AUR106	Aurigene Discovery Technologies Limited	Relapse, Advanced Malignant Neoplasm, Non Small Cell Lung Cancer, Gastric Cancer, Urothelial Carcinoma, Kidney Cancer, Colon Cancer, Esophagus Cancer	05/25	06/25
NCT05865002: A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)	Recruiting	1	50	RoW	AUR107	Aurigene Discovery Technologies Limited	Relapsed Malignant Solid Neoplasm	06/25	06/27
ASHA-1, NCT05984147: A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas	Recruiting	1	40	RoW	AUR108	Aurigene Discovery Technologies Limited	Relapsed Advanced Lymphomas	08/25	08/27
BHARAT-1, NCT05607199: A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics	Recruiting	1	80	RoW	AUR103, AUR 103 Calcium	Aurigene Discovery Technologies Limited	Solid Tumor, Adult, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non Hodgkin Lymphoma	09/25	10/26
SYN 20-01, NCT05094089: Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application	Recruiting	N/A	320	Europe, US	Hernia repair with mesh	W.L.Gore & Associates	Hernia, Ventral, Hernia Incisional, Hernia Incisional Ventral	12/25	12/28
Blanco, Alberto
NCT04641143: Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder	Recruiting	3	700	US	Troriluzole, Placebo	Biohaven Pharmaceuticals, Inc.	Obsessive-Compulsive Disorder	12/24	12/24
RETHINK-1, NCT04994483: Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease	Active, not recruiting	3	750	Canada, US, RoW	Simufilam, PTI-125, Placebo	Cassava Sciences, Inc., Premier Research Group plc	Alzheimer Disease	10/24	10/24
NCT05490680: A New Sildenafil Oral Film in Patients With Erectile Dysfunction	Recruiting	3	488	US	Sildenafil Oral Film 25 mg, 50 mg, 75 mg or 100 mg, Sildenafil Orodispersible Film, Placebo, Placebo-controlled	IBSA Institut Biochimique SA	Erectile Dysfunction	10/24	12/24
NCT05245422: Acceptance of a Partially Hydrolyzed Formula	Completed	N/A	148	US	Infant Formula - Partially hydrolyzed protein, Infant Formula - Intact protein	Mead Johnson Nutrition	Fussy Infant (Baby)	07/23	07/23